Four-Year Interim Results of the Safety of Augmentation Mammaplasty Using the Motiva Ergonomix™ Round SilkSurface: A Multicenter, Retrospective Study.

Aesthetic plastic surgery 2021 Vol.45(3) p. 895-903

Hong P, Kim SS, Jeong C, Hwang SH, Kim TS, Park JH, Song YG, Song YK

관련 도메인

Abstract

[BACKGROUND] The Motiva Ergonomix™ Round SilkSurface (Establishment Labs Holdings Inc., Alajuela, Costa Rica) is the fifth generation of a silicone gel-filled breast implant that is commercially available in Korea.

[OBJECTIVES] In this study, we describe 4-year interim results of the safety of augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface in Korean women.

[METHODS] In the current multicenter, retrospective study, we performed a retrospective review of medical records of a total of 1314 patients who received augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface at our hospitals between September 1, 2016, and August 31, 2020. For safety assessment, we analyzed incidences of postoperative complications and Kaplan-Meier complication-free survival of the patients.

[RESULTS] We included a total of 873 patients (1746 breasts, mean age = 32.18 ± 6.88 years) in the current study. There were a total of 111 cases (12.70%) of postoperative complications; these include 24 cases (2.70%) of early seroma, 18 cases (2.10%) of hematoma, 18 cases (2.10%) of capsular contracture, 17 cases (1.95%) of dissatisfaction with shape, 16 cases (1.83%) of dissatisfaction with size, 9 cases (1.03%) of asymmetry, 6 cases (0.70%) of infection and 3 cases (0.34%) of rippling. Moreover, time-to-events were estimated at 918.34 ± 36.22 days (95% CI 845.44-988.52).

[CONCLUSIONS] Here, we describe 4-year interim results of the safety of augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface in Korean women in a non-manufacturer-sponsored study. But further large-scale, prospective, multicenter studies with a long period of follow-up are warranted to establish our results.

[LEVEL OF EVIDENCE IV] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to Table of Contents or the online Instructions to Authors www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 mammaplasty 유방성형술 dict 4
해부 breast 유방 dict 1
합병증 hematoma 혈종 dict 1
합병증 seroma 장액종 dict 1
합병증 infection 감염 dict 1
합병증 capsular contracture 피막구축 dict 1
합병증 asymmetry 비대칭 dict 1
약물 [BACKGROUND] scispacy 1
약물 Labs scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 silicone gel-filled breast implant C0741713
Silicone gel-filled breast implant
scispacy 1
질환 1746 breasts scispacy 1
질환 breasts scispacy 1
기타 women scispacy 1
기타 patients scispacy 1

MeSH Terms

Adult; Breast Implantation; Breast Implants; Female; Follow-Up Studies; Humans; Mammaplasty; Prospective Studies; Republic of Korea; Retrospective Studies; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문